ARROWHEAD PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -166 %, a 282% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Equity for 2023 was -53.6 %, a 30.8% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Equity for 2022 was -41 %, a 27.1% decline from 2021.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Equity for 2021 was -32.3 %, a 85.9% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -166 -123 -282% Apr 1, 2024 Jun 30, 2024
Q1 2024 -141 -106 -311% Jan 1, 2024 Mar 31, 2024
Q4 2023 -90.8 -55.3 -156% Oct 1, 2023 Dec 31, 2023
Q3 2023 -53.6 -12.6 -30.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -43.6 -7.54 -20.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.3 -7.48 -27.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35.5 +8.49 +19.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -41 -8.74 -27.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -36.1 -8.05 -28.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.8 -3.13 -13.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -44 -22.4 -104% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.3 -14.9 -85.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -28 -22.4 -396% Apr 1, 2021 Jun 30, 2021
Q1 2021 -23.6 -26.3 -1007% Jan 1, 2021 Mar 31, 2021
Q4 2020 -21.6 -39.8 -218% Oct 1, 2020 Dec 31, 2020
Q3 2020 -17.4 -49.7 -154% Jul 1, 2020 Sep 30, 2020
Q2 2020 -5.65 -31.9 -121% Apr 1, 2020 Jun 30, 2020
Q1 2020 2.61 -4.12 -61.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 18.2 +42.5 Oct 1, 2019 Dec 31, 2019
Q3 2019 32.3 +89.5 Jul 1, 2019 Sep 30, 2019
Q2 2019 26.3 +85.7 Apr 1, 2019 Jun 30, 2019
Q1 2019 6.72 +56.8 Jan 1, 2019 Mar 31, 2019
Q4 2018 -24.2 +18.3 +43% Oct 1, 2018 Dec 31, 2018
Q3 2018 -57.2 -19.1 -50.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -59.4 -10.5 -21.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -50.1 +19.3 +27.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -42.5 +49.1 +53.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -38.1 +63.8 +62.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -48.9 +51.6 +51.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -69.3 +10.1 +12.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -91.6 -17.3 -23.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -102 -32.6 -46.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -100 -39.4 -64.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -79.4 -26.3 -49.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -74.3 -33.2 -80.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -69.4 -31.7 -84% Jul 1, 2015 Sep 30, 2015
Q2 2015 -61.1 -19.7 -47.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -53.2 +0.65 +1.21% Jan 1, 2015 Mar 31, 2015
Q4 2014 -41.1 +62.3 +60.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -37.7 +139 +78.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -41.4 +129 +75.7% Apr 1, 2014 Jun 30, 2014
Q1 2014 -53.8 +291 +84.4% Jan 1, 2014 Mar 31, 2014
Q4 2013 -103 +152 +59.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -177 +12.7 +6.67% Jul 1, 2013 Sep 30, 2013
Q2 2013 -170 -16.4 -10.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -345 -246 -250% Jan 1, 2013 Mar 31, 2013
Q4 2012 -255 Oct 1, 2012 Dec 31, 2012
Q3 2012 -190 Jul 1, 2012 Sep 30, 2012
Q2 2012 -154 Apr 1, 2012 Jun 30, 2012
Q1 2012 -98.5 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.